1. Home
  2. SRRK vs PPTA Comparison

SRRK vs PPTA Comparison

Compare SRRK & PPTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$45.04

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Logo Perpetua Resources Corp.

PPTA

Perpetua Resources Corp.

HOLD

Current Price

$26.67

Market Cap

4.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRRK
PPTA
Founded
2012
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
4.0B
IPO Year
2018
2011

Fundamental Metrics

Financial Performance
Metric
SRRK
PPTA
Price
$45.04
$26.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
3
Target Price
$55.40
$36.17
AVG Volume (30 Days)
1.1M
1.3M
Earning Date
03-03-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.67
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$449.79
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.71
$8.84
52 Week High
$49.82
$37.37

Technical Indicators

Market Signals
Indicator
SRRK
PPTA
Relative Strength Index (RSI) 52.17 36.36
Support Level $41.54 $26.03
Resistance Level $48.29 $30.77
Average True Range (ATR) 2.49 1.92
MACD -0.28 -0.76
Stochastic Oscillator 62.43 7.35

Price Performance

Historical Comparison
SRRK
PPTA

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About PPTA Perpetua Resources Corp.

Perpetua Resources Corp is focused on the exploration, site restoration, and redevelopment of gold-antimony-silver deposits in the Stibnite-Yellow Pine district of central Idaho that are encompassed by the Stibnite Gold Project. The Project is one of the highest-grade, open-pit gold deposits in the United States and is designed to apply a modern, responsible mining approach to restore an abandoned mine site and produce both gold and the only mined source of antimony in the United States. It has one segment, mineral exploration in the United States.

Share on Social Networks: